Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier

Molecular Biology Reports

Volumn 41, Issue 11, 2014, Pages 7313-7322

  Gu, Di ^a   Huang, Jun ^a   Yin, Youle ^a   Shan, Zhengfei ^a   Zheng, Shaobin ^a   Wu, Peng ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Bladder epithelial barrier; Cystitis; Ketamine; Rats; Urinary frequency

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP51; INDUCIBLE NITRIC OXIDE SYNTHASE; KETAMINE; OCCLUDIN; POTASSIUM ION; PROTEIN ZO1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYSTITIS; DRUG ABUSE; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; POTASSIUM URINE LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; URINARY FREQUENCY; URINE VOLUME; WESTERN BLOTTING; ADDICTION; ANIMAL; BLADDER; CHEMICALLY INDUCED; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM; HISTOLOGY; METABOLISM; URINE;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CYSTITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIUM; HISTOLOGICAL TECHNIQUES; IMMUNOHISTOCHEMISTRY; KETAMINE; RATS; SUBSTANCE-RELATED DISORDERS; URINARY BLADDER; URINE;

EID: 84917699508     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3616-5     Document Type: Article

References (33)

1. Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW, Man CW et al (2007) ‘Street ketamine’-associated bladder dysfunction: a report of ten cases. Hong Kong Med J 13:311–313
2. Persson J (2010) Wherefore ketamine? Curr Opin Anaesthesiol 23:455–460
3. Lai Y, Wu S, Ni L, Chen Z, Li X, Yang S et al (2012) Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity. Urol Int 89:93–96
4. Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH, Wong S et al (2008) The destruction of the lower urinary tract by ketamine abuse: a new syndrome? BJU Int 102:1616–1622
5. Yeung LY, Rudd JA, Lam WP, Mak YT, Yew DT (2009) Mice are prone to kidney pathology after prolonged ketamine addiction. Toxicol Lett 191:275–278
6. Tan S, Chan WM, Wai MS, Hui LK, Hui VW, James AE et al (2011) Ketamine effects on the urogenital system—changes in the urinary bladder and sperm motility. Microsc Res Tech 74:1192–1198
7. Wood D, Cottrell A, Baker SC, Southgate J, Harris M, Fulford S et al (2011) Recreational ketamine: from pleasure to pain. BJU Int 107:1881–1884
8. Ratliff TL, Klutke CG, McDougall EM (1994) The etiology of interstitial cystitis. Urol Clin North Am 21:21–30
9. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142
10. Matter K, Balda MS (2003) Signalling to and from tight junctions. Nat Rev Mol Cell Biol 4:225–236
11. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ (2004) Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 171:1554–1558
12. Zhang CO, Wang JY, Koch KR, Keay S (2005) Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 174:2382–2387
13. Keay SK, Zhang CO, Shoenfelt J, Erickson DR, Whitmore K, Warren JW et al (2001) Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 57:9–14
14. Erickson DR (2001) Urine markers of interstitial cystitis. Urology 57:15–21
15. Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69:34–40
16. Parsons CL (2011) The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int 107:370–375
17. Xu DZ, Lu Q, Deitch EA (2002) Nitric oxide directly impairs intestinal barrier function. Shock 17:139–145
18. Parsons CL, Greene RA, Chung M, Stanford EJ, Singh G (2005) Abnormal urinary potassium metabolism in patients with interstitial cystitis. J Urol 173:1182–1185
19. Shupp Byrne DE, Sedor JF, Soroush M, McCue PA, Mulholland SG (2001) Interaction of bladder glycoprotein GP51 with uropathogenic bacteria. J Urol 165:1342–1346
20. Nomiya A, Nishimatsu H, Homma Y (2011) Interstitial cystitis symptoms associated with ketamine abuse: the first Japanese case. Int J Urol 18:735
21. Erickson DR, Tomaszewski JE, Kunselman AR, Stetter CM, Peters KM, Rovner ES et al (2008) Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol 179:1850–1856
22. Lundberg JO, Ehren I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg E et al (1996) Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 48:700–702
23. Birder LA, Wolf-Johnston A, Buffington CA, Roppolo JR, de Groat WC, Kanai AJ (2005) Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. J Urol 173:625–629
24. Keay S, Zhang CO, Trifillis AL, Hise MK, Hebel JR, Jacobs SC et al (1996) Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156:2073–2078
25. Keay S (2008) Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 20:2174–2179
26. Keay S, Leitzell S, Ochrzcin A, Clements G, Zhan M, Johnson D (2012) A mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot study. BMC Urol 12:17
27. Zacharias DA, Mullen M, Planey SL (2012) Antiproliferative factor-induced changes in phosphorylation and palmitoylation of cytoskeleton-associated protein-4 regulate its nuclear translocation and DNA binding. Int J Cell Biol 2012:150918
28. Shahjee HM, Koch KR, Guo L, Zhang CO, Keay SK (2010) Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res 29:160
29. Adamowicz P, Kala M (2005) Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration: method and detection window considerations. J Anal Toxicol 29:376–382
30. Liu L, Wei ZW, Jia J, Wang YJ (2010) Toxicokinetics of ketamine in rabbits. Fa Yi Xue Za Zhi 26:357–360
31. Byrne DS, Sedor JF, Estojak J, Fitzpatrick KJ, Chiura AN, Mulholland SG (1999) The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol 161:1786–1790
32. Parsons CL, Bautista SL, Stein PC, Zupkas P (2000) Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 164:1381–1384
33. Parsons CL, Hurst RE (1990) Decreased urinary uronic acid levels in individuals with interstitial cystitis. J Urol 143:690–693